Welcome to our dedicated page for Agilon Health news (Ticker: AGL), a resource for investors and traders seeking the latest updates and insights on Agilon Health stock.
The agilon health, inc. (AGL) news page on Stock Titan aggregates company-specific updates for investors and observers who follow its role in value-based healthcare. agilon health describes itself as a trusted partner empowering physicians to transform health care in their communities, and its news flow reflects this focus on physician partnerships and senior care.
Company announcements commonly cover financial results, including quarterly earnings releases that discuss membership on the agilon platform, revenue from medical services, and performance within its value-based care arrangements. These releases often provide detail on metrics related to Medicare Advantage members and other value-based models for senior patients.
agilon health news also includes items on leadership and governance, such as changes in executive roles, the establishment of an Office of the Chairman, and updates on board-level decisions. In addition, the company frequently announces participation in healthcare and investor conferences, where its management team discusses the business, its Total Care Model, and its value-based care strategy.
Another recurring theme in agilon health’s news is research related to value-based care. The company has highlighted studies examining how its model may relate to clinical and quality outcomes, healthcare utilization, and access to primary care for Medicare patients. These research-focused releases describe how physicians working within agilon’s value-based care framework manage senior patients and how payment models may influence practice patterns.
Visitors to this page can review these types of updates in one place, from earnings announcements and NYSE compliance notices to conference appearances and research publications connected to agilon health’s value-based Total Care Model for senior patients.
agilon health (NYSE: AGL) reported challenging second quarter 2025 results, with total revenue declining 6% year-over-year to $1.39 billion. The company experienced significant headwinds, including a $66 million prior period development impact and an $85 million reduction in risk adjustment revenue. Total platform membership decreased to 614,000, including 498,000 Medicare Advantage members.
The company reported a net loss of $104 million compared to a $31 million loss in Q2 2024, and negative medical margin of $53 million versus positive $106 million in the prior year. Following these results and a leadership change with CEO Steven Sell stepping down, agilon has suspended its full-year 2025 guidance. The company maintains a solid capital position with $327 million in cash and marketable securities.
agilon health (NYSE: AGL) announced a significant leadership transition as CEO Steven Sell steps down from his roles as President, CEO, and Board Director. Ronald A. Williams, the company's co-founder and Board Chairman since 2017, has been appointed Executive Chairman to lead the transition.
The Board has established an Office of the Chairman to manage interim operations and has initiated a search for a permanent CEO. The Office includes key executives such as the CFO, CMO, and other senior leaders. Additionally, the company has withdrawn its full year 2025 earnings guidance in conjunction with this leadership change.
Williams, a healthcare industry veteran and former Chairman and CEO of Aetna, will focus on driving operational improvements and supporting physician partners while the search for a new CEO is conducted.
agilon health (NYSE: AGL) has scheduled its second quarter 2025 financial results announcement for Tuesday, August 5, 2025, after market close. The company will host a conference call at 4:30 PM Eastern Time on the same day to discuss the results.
Participants can join the call by dialing (833) 470-1428 (U.S.) or +1 (404) 975-4839 (international) using code 938716. A simultaneous webcast will be available on the company's investor relations website, with an on-demand replay accessible after the call.
agilon health (NYSE: AGL) announced its participation in Bernstein's 41st Annual Strategic Decisions Conference. The company will deliver a fireside chat presentation on Wednesday, May 28 at 4:30 PM Eastern Time. Investors can access the live webcast through agilon's investor relations website at investors.agilonhealth.com, with on-demand replays available shortly after the presentation.
agilon health (NYSE: AGL) reported its Q1 2025 financial results, showing a mixed performance with some declines but improved profitability. The company posted total revenues of $1.53 billion, down 4% from Q1 2024. Total platform members decreased to 605,000, including 491,000 Medicare Advantage members and 114,000 ACO REACH beneficiaries, reflecting previously disclosed market exits.
The company achieved net income of $12 million in Q1 2025, compared to a net loss of $6 million in Q1 2024. Medical margin was $128 million, down from $157 million, while Adjusted EBITDA decreased to $21 million from $29 million. The company maintains a strong capital position with $369 million in cash and equivalents and $35 million in total debt.
agilon health reaffirmed its full-year 2025 guidance, projecting total revenues between $5.85-6.025 billion and expects medical cost trends of 6.3% gross and 5.3% net for year 2+ markets.
agilon health (NYSE: AGL) has announced its participation in the upcoming BofA Securities 2025 Health Care Conference. The company will deliver a fireside chat presentation on Wednesday, May 14 at 1:00 PM Eastern Time.
Investors and interested parties can access the presentation through a simultaneous webcast available on the 'Events & Presentations' section of agilon health's investor relations website. On-demand replay options will be made available shortly after the presentation concludes.
agilon health (NYSE: AGL) has scheduled the release of its first quarter 2025 financial results after market close on Tuesday, May 6, 2025. The company will host a conference call at 4:30 PM Eastern Time on the same day to discuss the results.
U.S. participants can join the call by dialing (833) 470-1428, while international participants can dial +1 (404) 975-4839, using participant code 095319. A simultaneous webcast will be available through the 'Events & Presentations' section of agilon's Investor Relations website. An on-demand replay will be accessible shortly after the call concludes.
agilon health (NYSE: AGL) reported its Q4 and full-year 2024 results, showing significant membership growth but facing financial challenges. Total revenue increased 44% to $1.52 billion in Q4 2024, while full-year revenue grew 40% to $6.06 billion.
Medicare Advantage membership rose 36% year-over-year to 527,000 members, with total platform members reaching 659,000. However, the company faced profitability challenges with a Q4 gross profit of negative $38 million and a net loss of $106 million.
For 2025, agilon expects approximately 20,000 new Medicare Advantage members from Class of 2025, while planning to exit partnerships affecting 54,000 members. The company projects continued elevated medical cost trends, with an estimated gross cost trend of 6.3% and 5.3% net for year 2+ markets.